To include your compound in the COVID-19 Resource Center, submit it here.

Dovitinib lactate: Phase II data

An open-label, international Phase II trial in 20 evaluable patients with hormone receptor-positive/FGFR1+ metastatic breast cancer showed

Read the full 172 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE